SeaCrest Wealth Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

SeaCrest Wealth Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Sell	23,447 -3,176	-12%	-$45.7K	0.04%	371
2026 Q1	$382K	Sell	26,623 -2,228	-8%	-$33.1K	0.04%	405
2025 Q4	$449K	Buy	28,851 +304	+1%	+$4.56K	0.05%	347
2025 Q3	$428K	Buy	28,547 +1,747	+7%	+$24.8K	0.05%	349
2025 Q2	$382K	Buy	26,800 +2,245	+9%	+$32.1K	0.04%	389
2025 Q1	$366K	Buy	+24,555	New	+$384K	0.04%	418

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

SeaCrest Wealth Management's BMEZ Position: Q2 2026 in Review

SeaCrest Wealth Management reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 12% in Q2 2026, selling an estimated $45.7K and leaving 23,447 shares worth $360K. The position accounts for 0.04% of the portfolio, ranked #371.

SeaCrest Wealth Management first reported a position in BMEZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $449K in Q4 2025. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

SeaCrest Wealth Management held 23,447 shares of BlackRock Health Sciences Trust II worth $360K as of Q2 2026.
SeaCrest Wealth Management sold 3,176 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $45.7K.
BlackRock Health Sciences Trust II made up 0.04% of SeaCrest Wealth Management's portfolio in Q2 2026, its #371 holding.
SeaCrest Wealth Management first reported a position in BlackRock Health Sciences Trust II in Q1 2025 and has held it in 6 quarters since.
SeaCrest Wealth Management's BlackRock Health Sciences Trust II position peaked at $449K in Q4 2025.
89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.